Experts

Introduction

Accelerate@Babraham is underpinned by a group of talented, highly experienced individuals whose collective motivation is to share their experiences to ensure our next generation of life science start-ups can learn from those that have ‘been there, done it’ before. They are all passionate about the sector, and unafraid to challenge and be challenged. Find out more about some of them here…

Khatereh Ahmadi

Khatereh Ahmadi has worked in the biotech/pharma industry for 15 years. Previous to her current role at MSD/Merck as Executive Director, she was a co-founder and CEO of reViral Ltd.

Read more

Lilian Alcaraz

Lilian is Senior Director, New Ventures and Transactions lead for Neuroscience, at Johnson & Johnson Innovation.

Read more

Jelena Aleksic

Jelena is a geneticist and serial entrepreneur, passionate about the potential of biotechnology to improve patients' lives.

Read more

Ala Alenazi

Ala is an Investment Associate at Ascension Life Fund, responsible for deal-flow, portfolio management and technical due diligence.

Read more

Nazira Amra

Nazira Amra is a trained physician and experienced pharmaceutical commercial leader who has spent the last 20+ years working at the intersection of both strategy and operations in pharma.

Read more

Bobby Anderson

Bobby Anderson is a Vice President at Silicon Valley Bank in their Life Science and Healthcare practice.

Read more

Michael Anstey

Dr Michael Anstey is a Partner specialising in life science investments.

Read more

Charli Batley

Having completed my PhD in Biochemistry at Reading, I very quickly decided that research was not for me. I became a sales rep, where I met Chris Torrance just after he had started Horizon Discovery.

Read more

Sam Barker

Sam Barker is the Business Development and Alliance Manager at PhoreMost Ltd. Sam joined PhoreMost in 2016 as a scientist in the drug discovery team.

Read more

Maina Bhaman

Maina is an investor with a focus on early stage technology companies, specifically biotechnology and medical devices.

Read more

Keith Blundy

Keith joined STORM Therapeutics as CEO in January 2017. Prior to STORM, Keith was Chief Executive of Cancer Research Technology Ltd, the commercial arm of Cancer Research UK.

Read more

Sarah Brereton

As Director of Limewash, a strategic marketing agency, Sarah helps clients understand their customers, propositions and processes better, before working with them to develop communications.

Read more

Brian Burke

Brian is an experienced life sciences business leader with a strong track record of success in both strategy and execution.

Read more

Marco Cerato

Marco joined the Mundipharma network of independent associated companies in 2018 further enhance our external partnerships and medicine pipeline.

Read more

Hugo Christie

Hugo works in the Commercial and Technology team of Taylor Vinters, a law firm focussed on the innovation economy and supporting entrepreneurial ventures.

Read more

Mary Clark

Mary has a 25-year successful track record in providing strategic corporate and financial communications to both early- and late-stage healthcare companies.

Read more

Peter Crane

Peter is a venture investor at Luminous Ventures a late-seed investor based in the UK.

Read more

Jane Dancer

Jane has over 30 years’ experience in the life science industry across biotech, pharma and agrochemicals.

Read more

Cassie Doherty

Cassie is an Investment Director with Parkwalk Advisors specialising in Healthcare and Life Sciences.

Read more

Daria Donati

Daria Donati is leading the Cytiva and Bioprocess Business inorganic pipeline, driving growth through M&A and strategic investments for the bioprocess business.

Read more

Steve Dowd

Steve has over 20 years biotechnology and pharmaceutical industry experience in both business development and R&D. He is currently Senior Director of Business Development at Kymab.

Read more

Laura Ferguson

Laura is passionate about supporting life science innovation and connecting the early innovation ecosystem. She has a background in academia and experience in entrepreneurship and finance.

Read more

David Ford

David is an Oxford-based life sciences angel investor. Since 2016 he has been focused on early-stage investing, managing the Arrowfield Capital syndicate.

Read more

Eliot Forster

Eliot has more than 25 years of experience in the pharmaceutical and biotechnology industry and previously served as Chief Executive Officer of Immunocore, Creabilis Therapeutics and Solace Pharmaceuticals.

Read more

David Grainger

Following an academic career at Cambridge University spanning 20 years, leading a world-renowned group, David joined Index Ventures.

Read more

Jeremy Griggs

Jeremy is a Senior Director in GSK R&D's Worldwide Business Development Team, with a focus on identifying and evaluating innovative emerging science, drugs and technologies.

Read more

Vishal Gulati

Vishal Gulati is a venture partner at Draper Esprit a leading European venture capital firm. His investment interests include healthtech, omics and synthetic biology.

Read more

Joanne Hackett

Joanne M. Hackett is the Head of Genomic and Precision Medicine at IQVIA and previously was the Chief Commercial Officer at Genomics England.

Read more

Hermann Hauser

Serial Entrepreneur and Co-founder of Amadeus Capital Partners, Dr Hermann Hauser KBE has wide experience in developing and financing companies in the information technology sector.

Read more

Theodora Harold

Theodora Harold was appointed CEO of Crescendo Biologics (Crescendo) in May 2019.

Read more

Miao He

Miao focuses on early stage ventures in biotechnology and life sciences. She is an investment professional at Luminous Ventures, a UK-based venture capital firm focusing on human health and deep tech

Read more

David Holbrook

David Holbrook is a qualified physician who has spent thirty-five years in medicine and medical innovation, and the last twenty in life sciences spinout investing, principally from academia.

Read more

Jackie Hunter

Jackie Hunter is currently a Board Director of BenevolentAI, a UK unicorn company that uses artificial intelligence to disrupt the drug discovery and development process.

Read more

Steve Jackson

Steve Jackson FRS, FMedSci is University of Cambridge and Cancer Research UK Professor of Biology, and Head of Cancer Research UK Laboratories at the Gurdon Institute.

Read more

Stewart Kay

Stewart joined Crescendo in 2019 as Chief Business Officer and has over 20 years’ experience in business development.

Read more

Michael Kipping

Michael is a Health Innovation Lead at Innovate UK and responsible for the Biomedical Catalyst grant funding programme that supports UK life science SMEs. 

Read more

Mark Lees

Mark has worked in a range of business consulting roles and biotech companies, including a UCL spin out.

Read more

Pablo Lubroth

Pablo focuses on biotechnology and healthcare ventures. Previously, Pablo was an Investment Manager at Midven, a UK based early-stage biotech fund.

Read more

Tim Luker

Tim Luker is currently VP External Innovation at Eli Lilly. He leads Lilly's external advancing innovation process within Global Corporate Business Development.

Read more

Salvatore Di Maggio

Salvatore is an International Tax Lawyer based in Cambridge, with a degree in Economics.

Read more

Allan Marchington

Allan Marchington is a founder and Managing Partner at Bridge Valley Ventures a UK based Life Science investor which was established by LifeArc of the UK leading medical charities.

Read more

Christine Martin

As Head of Life Science Investment within the Life Sciences team at Cambridge Enterprise Christine focuses on drug discovery and is responsible for a broad portfolio.

Read more

Jolyon Martin

Jolyon is co-founder and Head of Business Development at PetMedix, a Cambridge-based biopharmaceutical company developing antibody-based therapeutics for companion animals.

Read more

Jonathan Milner

Jonathan Milner is an experienced entrepreneur and investor who is passionate about supporting UK life science and high-tech start-ups.

Read more

Tim Minshall

Tim is the inaugural Dr John C Taylor Professor of Innovation at the University of Cambridge, Head of the Institute for Manufacturing and Head of the IfM’s Centre for Technology Management.

Read more

Mariam Mirza

Mariam is a Business Psychologist Consultant at OE Cam, focusing on the assessment and development of individuals and teams.

Read more

Kate Moss

Kate is a Management Consultant in the life sciences Industry specialised in helping companies implement strategy through the development of capabilities and positive engagement.

Read more

Rabab Nasrallah

Rabab Nasrallah is an investment professional with Earlybird Venture Capital based in Germany.

Read more

Natalia Novac

Natalia Novac is a part of the Emerging Technology and Innovation Group and is responsible for search and evaluation of novel healthcare technologies across all Eli Lilly indications in Europe.

Read more

Jane Osbourn

Jane was an early employee of Cambridge Antibody Technology, which became MedImmune, the global biologics research and development arm of AstraZeneca.

Read more

Peju Oshisanya

Peju has worked in the clinical research industry for over 15 years during which she has acquired wide-ranging experience.

Read more

Jo Parfrey

Jo Parfrey is an experienced and successful investment professional with more than 10 years in the private equity industry.

Read more

Pierre Peotta

Pierre has over ten years of experience in Marketing, Communications and Sales in the Life Science sector, built up across a range of businesses.

Read more

Chris Poole

Chris has over 25 years’ experience in finance, holding senior positions at a variety of organisation types mostly ranging from business start-ups through to mid-size.

Read more

Oli Rayner

Oli is an entrepreneur and deal maker with a track record in the early stage healthcare and life sciences sector.

Read more

Jill Reckless

In April 2013, Jill Reckless co-founded RxCelerate Ltd with David Grainger, an out-sourcing drug discovery and development platform.

Read more

Andy Richards

Andy Richards is an entrepreneur and investor with an established track record in founding and scaling up innovative Biotech and Healthtech companies in the UK.

Read more

Nicholas Stern

Nicholas has over 18 years’ experience in finance, with significant experience advising a wide variety of organisations, ranging from small start-ups through to large multinational organisations.

Read more

Kai Stoeber

Kai Stoeber is Senior Director, External Innovation at Johnson & Johnson Innovation.

Read more

Nick Tait

Nick is the Group CFO of RxCelerate and managing director of its Cambridge Partnership subsidiary.

Read more

Anne Tiney

With an HR background gained in various drug discovery organisations, Anne joined Mission Therapeutics in 2016 as Vice President, Human Resources.

Read more

Rebecca Todd

Dr Rebecca Todd is an Investment Director with Longwall Ventures managing early stage investments in health tech and life sciences companies.

Read more

Neil Torbett

Neil is an experienced biotechnology professional with over 15 years of research and management experience in the biotechnology industry.

Read more

Chris Torrance

Dr Chris Torrance is a cancer researcher and entrepreneur. In 2007 he founded Horizon Discovery to translate advances in human genome editing.

Read more

Abel Ureta-Vidal

Scientist, serial entrepreneur, accomplished C-suite executive, data strategist, mentor/coach and investor with decades of experience in life sciences, more specifically in genomics, and digital fields.

Read more

Malti B Vaghela

Malti is a Consultant at Boston Consulting Group (BCG), a global management consulting firm, with a particular focus on Healthcare.

Read more

Paul Wallace

Paul has over 25 years’ leadership experience in business development. Currently he is CBO for Mission Therapeutics, located on the Babraham Research Campus.

Read more

David Weston

David is an Associate Director in AstraZeneca’s Emerging Innovations Unit, where he is responsible for driving entrepreneurial activities and identifying game-changing technologies.

Read more

Anna Williamson

Anna Williamson is a Director of Business Development at Roche Pharma Partnering and the Head of Roche’s Cambridge Innovation Hub providing business development support.

Read more

Marcus Yeo

Marcus Yeo is a founder and CEO of DefiniGEN. He is an experienced Company Director and life scientist.

Read more